A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07465120 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07465120
- Sponsor
- Dermavon Holdings Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-20
- Primary completion
- 2027-01-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.